Clinical trial
Timing of Anti-vascular Endothelial Growth Factor(Anti-VEGF) Intravitreous Injections for Diabetic Macular Edema(DME) in Patients Undergoing Cataract Surgery
NCT04063358 is registered in ClinicalTrials.gov with Second Military Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Timing of Anti-vascular Endothelial Growth Factor(Anti-VEGF) Intravitreous Injections for Diabetic Macular Edema(DME) in Patients Undergoing Cataract Surgery
- Lead sponsor
- Second Military Medical University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- August 22, 2019
- Completion date
- August 31, 2021
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cataract, diabetic macular edema